(Q39534540)

12 September 2017

title

Treatment of unresectable pancreatic carcinoma using irradiation with concurrent intravenous 5-FU infusion therapy (English)

1 reference

12 September 2017

1 reference

Raju PI

1

1 reference

12 September 2017

Maruyama Y

series ordinal

2

1 reference

12 September 2017

MacDonald J

series ordinal

3

1 reference

12 September 2017

DeSimone P

series ordinal

4

1 reference

12 September 2017

publication date

1 January 1988

1 reference

12 September 2017

1 reference

12 September 2017

volume

6

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

263-266

1 reference

Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group report

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357908809080647

New surgical approaches to pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809080647

Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809080647

Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809080647

Cancer of the pancreas. Diagnostic accuracy and survival statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809080647

Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809080647

10.3109/07357908809080647

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference